Connection

Janet Fisher to Recombinant Fusion Proteins

This is a "connection" page, showing publications Janet Fisher has written about Recombinant Fusion Proteins.
Connection Strength

0.163
  1. ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy. J Immunother Cancer. 2020 04; 8(1).
    View in: PubMed
    Score: 0.150
  2. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. J Bone Miner Res. 2004 Nov; 19(11):1873-81.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.